Table 4.
Men (n=485) | Women (n=418) | |||||||
---|---|---|---|---|---|---|---|---|
10‐Year Risk* | Lifetime Risk | 10‐Year Risk* | Lifetime Risk | |||||
Low (n=243) | High (n=235) | Low (n=102) | High (n=383) | Low (n=359) | High (n=56) | Low (n=125) | High (n=293) | |
Age‐adjusted CAC prevalence, % | 46.2 | 67.9* | 47.9 | 64.4* | 18.5 | 26.2 | 8.9 | 23.3* |
Age‐adjusted CAC score, mean (SE) | 73.5 (0.7) | 97.4 (0.9) | 52.0 (0.6) | 95.3 (0.6)* | 44.7(1.5) | 82.1 (1.8) | 45.6 (1.2) | 56.3 (1.2) |
Presence of CAC, OR (95% CI) | Referent | 1.81 (1.0, 3.3)* |
Referent | 1.97 (1.2, 3.2)* |
Referent | 1.56 (0.7, 3.4) |
Referent | 3.14 (1.5, 6.6)* |
HDL indicates high‐density lipoprotein; MASALA, Mediators of Atherosclerosis in South Asians Living in America.
Participants who were missing HDL cholesterol (n=10) could not have 10‐year risk calculated and are not included in 10‐year risk strata.
P<0.01.
P<0.05.